Getinge AB Class B GNGBF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $25.00
- Day Range
- $23.39–23.39
- 52-Week Range
- $20.05–25.00
- Bid/Ask
- $0.00 / $3,626.17
- Shares Outstanding
- 272.37M
- Market Cap
- $6.37B
- Volume/Avg
- 151 / 129
Key Statistics
- Price/Earnings (Normalized)
- 19.59
- Price/Sales
- 1.74
- Dividend Yield (Trailing)
- 2.20%
- Dividend Yield (Forward)
- 2.20%
- Dividend Payment Schedule
- Apr
- Total Yield
- 2.20%
Company Profile
Getinge, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgical, and life sciences in the hospital, pharmaceutical, and research settings. The company reports in three segments: acute care therapies (52% of revenue), surgical workflows (35%), and life sciences (13%). Product areas include ventilators, surgical stents, life support systems, sterilizers, surgical tables, and sterile transfer systems. Getinge derives revenue from a broad geographic footprint, with the Americas accounting for 45% of sales, Europe, Middle East, and Africa 35%, and Asia-Pacific the remaining 25%.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Mid Core
- Total Number of Employees
- 11,758
- Website
- https://www.getinge.com
Competitors
Valuation
|
Metric
|
GNGBF
|
MDT
|
SYK
|
|---|---|---|---|
Price/Earnings (Normalized) | 19.59 | 16.43 | 20.25 |
Price/Book Value | 2.00 | 2.37 | 4.52 |
Price/Sales | 1.74 | 3.19 | 4.23 |
Price/Cash Flow | 11.29 | 13.35 | 19.34 |
Price/Earnings
GNGBF
MDT
SYK
Financial Strength
|
Metric
|
GNGBF
|
MDT
|
SYK
|
|---|---|---|---|
Quick Ratio | 0.74 | 1.29 | 1.08 |
Current Ratio | 1.31 | 2.07 | 2.16 |
Interest Coverage | 7.26 | 10.12 | — |
Quick Ratio
GNGBF
MDT
SYK
Profitability
|
Metric
|
GNGBF
|
MDT
|
SYK
|
|---|---|---|---|
Return on Assets (Normalized) | 5.85% | 8.31% | 11.44% |
Return on Equity (Normalized) | 11.17% | 15.59% | 23.97% |
Return on Invested Capital (Normalized) | 9.16% | 10.57% | 14.10% |
Return on Assets
GNGBF
MDT
SYK
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|jkYhx?T | LOCK|DKRd# | $178B | |||
| Medtronic PLC
MDT
| LOCK|lk@r<@S | LOCK|h^>v | $121B | |||
| Stryker Corp
SYK
| LOCK|%YMh!&Pm | LOCK|Xg? | $108B | |||
| Boston Scientific Corp
BSX
| LOCK|>C!&wt | LOCK|!D?Pt | $62B | |||
| Edwards Lifesciences Corp
EW
| LOCK|&T>wf<% | LOCK|^b#g | $50B | |||
| DexCom Inc
DXCM
| LOCK|!@%t<z&# | LOCK|s@@t | $31B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|wS?ms%> | LOCK|b!! | $31B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|j%^ | LOCK|R$ | $25B | |||
| Steris PLC
STE
| LOCK|N#mSdz | LOCK|>N&Mq | $21B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|jVSf@Mz | LOCK|D$b | $18B |
United States